Bessemer Group
IRWD icon

Bessemer Group’s Ironwood Pharmaceuticals IRWD Stock Holding History

Bessemer Group’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-932
Closed -$3K – 2598
2025
Q4 		$3K Hold
932
– – ﹤0.01% 2349
2025
Q3 		$1K Buy
+932
New +$965 ﹤0.01% 2422
2024
Q4 		– Sell
-547
Closed -$2K – 2559
2024
Q3 		$2K Buy
+547
New +$2.94K ﹤0.01% 2216
2024
Q2 		– Sell
-299
Closed -$3K – 2084
2024
Q1 		$3K Sell
299
-367
-55% -$4.45K ﹤0.01% 1855
2023
Q4 		$7K Hold
666
– – ﹤0.01% 1672
2023
Q3 		$7K Buy
666
+181
+37% +$1.77K ﹤0.01% 1663
2023
Q2 		$5K Buy
485
+112
+30% +$1.2K ﹤0.01% 1819
2023
Q1 		$4K Buy
+373
New +$4.18K ﹤0.01% 1661
2021
Q1 		– Sell
-477
Closed -$5K – 1565
2020
Q4 		$5K Buy
+477
New +$5.22K ﹤0.01% 1381
2016
Q2 		– Sell
-2,442
Closed -$22K – 1373
2016
Q1 		$22K Buy
+2,442
New +$20.1K ﹤0.01% 1044

Other funds holding IRWD

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Bessemer Group's IRWD Position: Q1 2026 in Review

Bessemer Group sold out of Ironwood Pharmaceuticals (IRWD) in Q1 2026, closing a stake of 932 shares — an estimated $3K sold.

Bessemer Group first reported a position in IRWD in Q1 2016 and held it in 10 quarters. The position peaked at $22K in Q1 2016. 226 funds tracked by Wall St. Rank hold IRWD as of Q1 2026.

  • Bessemer Group reported no remaining Ironwood Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Bessemer Group sold 932 Ironwood Pharmaceuticals shares in Q1 2026, an estimated $3K.
  • Bessemer Group first reported a position in Ironwood Pharmaceuticals in Q1 2016 and held it in 10 quarters.
  • Bessemer Group's Ironwood Pharmaceuticals position peaked at $22K in Q1 2016.
  • 226 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q1 2026.

Based on Bessemer Group's 13F filing for Q1 2026, filed 6 May 2026.